Pfizer Chief Scientific Officer: after six months there likely is the risk of coronavirus reinfection as antibodies wane

Pfizer Chief Scientific Officer Mikael Dolsten said the recently reported dip in the vaccine’s effectiveness in Israel was mostly due to infections in people who had been vaccinated in January or February....More...